Immunobiome and BalanceBrain Launch Offline Sales of 'Gut Health & Balance'

Immunobiome, an AI-based new drug research and development company, is accelerating its efforts to target the health functional food (HFF) market.

On the 27th, Immunobiome announced that it will exclusively sell 'Janggeon-gang & Balance' at Balance Brain, a nationwide brain total care center. Janggeon-gang & Balance is a probiotic HFF jointly developed by Immunobiome and Balance Brain.

Immunobiome visited Balance Brain's nationwide centers to provide explanations related to Janggeon-gang & Balance. The company plans to continue informing consumers about the impact of gut health on brain function through various methods.

Balance Brain is a brain balance exercise therapy center with 14 centers nationwide. It identifies the fundamental causes of symptoms such as childhood attention deficit hyperactivity disorder (ADHD), tic disorder, developmental delay, language delay, and autism spectrum, and provides customized programs for each symptom. In addition, it offers various services including step-by-step brain fitness programs, brain infant development programs, and brain nutrition consultation.

An Immunobiome representative said, “Janggeon-gang & Balance is an HFF containing a mixture of seven types of Lactobacillus and Bifidobacterium strains, as well as Immunobiome’s patented strain IMB01 (IMB002) developed in-house. We have carefully selected even the minor ingredients, so we ask for your great interest.”

Meanwhile, Balance Brain will hold a webinar on the gut-brain axis theory through the Brain Balance Research Institute’s YouTube channel in early next month. The webinar will introduce detailed information about the gut-brain axis theory and will host a live Q&A session to answer various questions.

This content was produced with the assistance of AI translation services.